US$ 26.65
how many people take glp 1 are taking for weight loss U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use GLP-1 Survey: 37.5% of People
Description
Adipose tissue failure forces the spillover of excessive free fatty acids (FFA) into the systemic circulation, causing ectopic fat deposition in non-adipose organs, including the skeletal muscle and, critically, the liver ( de novo lipogenesis and endogenous glucose production, thereby driving both hepatic steatosis and hyperglycemia

That is not because they do not know

Its free
But for people who currently use medications like Wegovy and Ozempic for weight loss, you may face one of the following issues that have become common across the U.S
These drugs have raised concerns due to their prescription for treating type 2 diabetes, which increases the risk of pancreatic cancer
